Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Schizophrenia Bulletin|November 25, 2011
Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systemsNeil Dawson, Brian J Morris, Judith A Pratt
Pharmacology & Therapeutics|February 25, 2014
Risk genes for schizophrenia: translational opportunities for drug discoveryCatherine L Winchester, Judith A Pratt, Brian J Morris
Current Opinion in Pharmacology|January 22, 2005
PCP: from pharmacology to modelling schizophreniaBrian J Morris, Susan M Cochran, Judith A Pratt
Disease Models & Mechanisms|March 11, 2022
The schizophrenia risk gene Map2k7 regulates responding in a novel contingency-shifting rodent touchscreen gambling taskRebecca L Openshaw, Judith A Pratt, Brian J Morris
Neuroscience and Biobehavioral Reviews|April 1, 2006
Cannabinoids and prefrontal cortical function: insights from preclinical studiesAlice Egerton, Claire Allison, Ros R Brett, et al.
Synapse (New York, N.Y.)|September 27, 2002
Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brainSusan M Cochran, Masatake Fujimura, Brian J Morris, et al.
Neuropharmacology|June 7, 2011
Chronic phencyclidine (PCP)-induced modulation of muscarinic receptor mRNAs in rat brain: impact of antipsychotic drug treatmentLucinda J Steward, Matthew D Kennedy, Brian J Morris, et al.
Neuropharmacology|September 24, 2004
The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptorsLucinda J Steward, Matthew D Kennedy, Brian J Morris, et al.
Pageof 5